There is a lot of activity in the area of software companies focusing on cell and gene therapy R&D. This panel explores some of the diverse approaches companies are taking to improve efficiency and avert pitfalls in therapeutic development.
This panel is sponsored by Komodo Health.
As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities
In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.
Moderator: John Reites, CEO, THREAD Research
Speakers:
- Aswin Chandrakantan, MD, Chief Medical Officer and Head of Life Sciences, Komodo Health
- Annie Harris, Director of Technology Enablement, Covance